Shares of LifePoint Health were dinged yesterday not only by the broad market malaise but also by Goldman Sachs analyst Matt Borsch, who took the Brentwood-based hospital operator off his 'buy' list but tweaked his price target to $78 from $81. The company, he said, still has 'a promising idiosyncratic growth story' as it targets smaller markets. But investors have been pounding hospital stocks in recent months, and Borsch sees more upside in other sectors. LifePoint shares (Ticker: LPNT) are off slightly this morning to about $67.40 after giving up 1.2 percent Wednesday.